Protecting Bioprocessing Operations And Supply Chains In A Turbulent Economy

Resilience is critical in biomanufacturing, especially in an increasingly connected global ecosystem where economic shifts in one region can threaten operations everywhere. This interactive panel discussion focused on how companies are navigating a tight funding environment, raw material shortages, and global market pressures to protect supply chains and operations. The panel featured Adam Golin, a senior director of manufacturing at Sanofi; Jon Lindbloom, the director of technical operations at Vaxart; and veteran industry leader James Sapirstein.